{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:31:39Z","timestamp":1789576299320,"version":"build-2803163510"},"reference-count":43,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"Sp. 1","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["Biomed."],"abstract":"<jats:p>La fusariosis es una micosis oportunista producida por Fusarium spp. Su presentaci\u00f3n cl\u00ednica depende del estado inmunol\u00f3gico del hu\u00e9sped, especialmente, el de aquellos con enfermedades hematooncol\u00f3gicas, cuyas manifestaciones var\u00edan desde formas localizadas hasta infecci\u00f3n f\u00fangica invasora. El cultivo de piel o de sangre permite orientar el tratamiento antif\u00fangico combinado con anfotericina B y voriconazol.Se presentan 13 casos de pacientes con c\u00e1ncer en un periodo de once a\u00f1os que desarrollaron fusariosis diseminada; asimismo, se hizo con una revisi\u00f3n extensa de la literatura.En esta serie de casos, la mortalidad fue del 61,5 % (8\/13), a pesar del uso del antif\u00fangico. De los 13 pacientes, 11 ten\u00edan neoplasia hematol\u00f3gica y 2 neoplasia s\u00f3lida. El factor de riesgo m\u00e1s importante fue la neutropenia profunda. El compromiso de la piel y los hemocultivos positivos facilitaron la prescripci\u00f3n del tratamiento combinado en la mayor\u00eda de los casos. La neutropenia febril persistente asociada a lesiones cut\u00e1neas, la onicomicosis, los n\u00f3dulos o las masas pulmonares permitieron sospechar una infecci\u00f3n f\u00fangica invasora por Fusarium spp.El objetivo de la presentaci\u00f3n de esta serie de casos es recordar el diagn\u00f3stico de fusariosis a la comunidad m\u00e9dica en contacto con pacientes oncol\u00f3gicos, con neutropenia febril profunda y persistentes.<\/jats:p>","DOI":"10.7705\/biomedica.6925","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T10:18:35Z","timestamp":1695032315000},"page":"41-56","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":5,"title":["Fusariosis en pacientes con c\u00e1ncer: serie de 13 casos y revisi\u00f3n de la literatura","Fusariosis in cancer patients: 13 case series report and literature review"],"prefix":"10.7705","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5676-880X","authenticated-orcid":false,"given":"Sonia Isabel","family":"Cuervo-Maldonado","sequence":"first","affiliation":[{"name":"Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia; Grupo de Infectolog\u00eda, Instituto Nacional de Cancerolog\u00eda, Bogot\u00e1, D.C., Colombia; Grupo de Investigaci\u00f3n en Enfermedades Infecciosas en C\u00e1ncer y Alteraciones Hematol\u00f3gicas (GREICAH), Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia"},{"name":"Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia; Grupo de Infectolog\u00eda, Instituto Nacional de Cancerolog\u00eda, Bogot\u00e1, D.C., Colombia; Grupo de Investigaci\u00f3n en Enfermedades Infecciosas en C\u00e1ncer y Alteraciones Hematol\u00f3gicas (GREICAH), Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7267-2461","authenticated-orcid":false,"given":"Jos\u00e9 Camilo","family":"\u00c1lvarez-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Grupo de Infectolog\u00eda, Instituto Nacional de Cancerolog\u00eda, Bogot\u00e1, D.C., Colombia; Grupo de Investigaci\u00f3n en Enfermedades Infecciosas en C\u00e1ncer y Alteraciones Hematol\u00f3gicas (GREICAH), Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia"},{"name":"Grupo de Infectolog\u00eda, Instituto Nacional de Cancerolog\u00eda, Bogot\u00e1, D.C., Colombia; Grupo de Investigaci\u00f3n en Enfermedades Infecciosas en C\u00e1ncer y Alteraciones Hematol\u00f3gicas (GREICAH), Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8241-9179","authenticated-orcid":false,"given":"Cristian Leonardo","family":"Cubides","sequence":"additional","affiliation":[{"name":"Grupo de Infectolog\u00eda, Instituto Nacional de Cancerolog\u00eda, Bogot\u00e1, D.C., Colombia; Grupo de Investigaci\u00f3n en Enfermedades Infecciosas en C\u00e1ncer y Alteraciones Hematol\u00f3gicas (GREICAH), Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia"},{"name":"Grupo de Infectolog\u00eda, Instituto Nacional de Cancerolog\u00eda, Bogot\u00e1, D.C., Colombia; Grupo de Investigaci\u00f3n en Enfermedades Infecciosas en C\u00e1ncer y Alteraciones Hematol\u00f3gicas (GREICAH), Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0880-8496","authenticated-orcid":false,"given":"Juan Camilo","family":"Barrera","sequence":"additional","affiliation":[{"name":"Grupo de Infectolog\u00eda, Instituto Nacional de Cancerolog\u00eda, Bogot\u00e1, D.C., Colombia; Grupo de Investigaci\u00f3n en Enfermedades Infecciosas en C\u00e1ncer y Alteraciones Hematol\u00f3gicas (GREICAH), Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia"},{"name":"Grupo de Infectolog\u00eda, Instituto Nacional de Cancerolog\u00eda, Bogot\u00e1, D.C., Colombia; Grupo de Investigaci\u00f3n en Enfermedades Infecciosas en C\u00e1ncer y Alteraciones Hematol\u00f3gicas (GREICAH), Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Diego","family":"Monta\u00f1ez-Abril","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia; Grupo de Investigaci\u00f3n en Enfermedades Infecciosas en C\u00e1ncer y Alteraciones Hematol\u00f3gicas (GREICAH), Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia"},{"name":"Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia; Grupo de Investigaci\u00f3n en Enfermedades Infecciosas en C\u00e1ncer y Alteraciones Hematol\u00f3gicas (GREICAH), Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5906-9593","authenticated-orcid":false,"given":"Erika Paola","family":"Vergara-Vela","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia"},{"name":"Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0068-6631","authenticated-orcid":false,"given":"Carlos Humberto","family":"Saavedra-Trujillo","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia; Grupo de Enfermedades Infecciosas, Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia"},{"name":"Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia; Grupo de Enfermedades Infecciosas, Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9865-9097","authenticated-orcid":false,"given":"Mar\u00eda Jos\u00e9","family":"L\u00f3pez-Mora","sequence":"additional","affiliation":[{"name":"Grupo de Investigaci\u00f3n en Enfermedades Infecciosas en C\u00e1ncer y Alteraciones Hematol\u00f3gicas (GREICAH), Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia; Grupo de Infectolog\u00eda, Cl\u00ednica de Marly, Bogot\u00e1, D.C., Colombi"},{"name":"Grupo de Investigaci\u00f3n en Enfermedades Infecciosas en C\u00e1ncer y Alteraciones Hematol\u00f3gicas (GREICAH), Facultad de Medicina, Universidad Nacional de Colombia, Bogot\u00e1, D.C., Colombia; Grupo de Infectolog\u00eda, Cl\u00ednica de Marly, Bogot\u00e1, D.C., Colombi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2717-9293","authenticated-orcid":false,"given":"Gloria Elena","family":"Mora-Figueroa","sequence":"additional","affiliation":[{"name":"Grupo de Infectolog\u00eda, Cl\u00ednica de Marly, Bogot\u00e1, D.C., Colombia"},{"name":"Grupo de Infectolog\u00eda, Cl\u00ednica de Marly, Bogot\u00e1, D.C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3057-1966","authenticated-orcid":false,"given":"Adriana","family":"Celis-Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Grupo de Investigaci\u00f3n Celular y Molecular de Microorganismos Pat\u00f3genos (CeMoP), Universidad de los Andes, Bogot\u00e1, D.C., Colombia"},{"name":"Grupo de Investigaci\u00f3n Celular y Molecular de Microorganismos Pat\u00f3genos (CeMoP), Universidad de los Andes, Bogot\u00e1, D.C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4474-9390","authenticated-orcid":false,"given":"Rose Mary","family":"Jaramillo-Calle","sequence":"additional","affiliation":[{"name":"Grupo de Infectolog\u00eda, Instituto Nacional de Cancerolog\u00eda, Bogot\u00e1, D.C., Colombia"},{"name":"Grupo de Infectolog\u00eda, Instituto Nacional de Cancerolog\u00eda, Bogot\u00e1, D.C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8428-5837","authenticated-orcid":false,"given":"Rafael","family":"Parra-Medina","sequence":"additional","affiliation":[{"name":"Grupo de Investigaci\u00f3n Patolog\u00eda Oncol\u00f3gica INC, Instituto Nacional de Cancerolog\u00eda, Bogot\u00e1, Colombia"},{"name":"Grupo de Investigaci\u00f3n Patolog\u00eda Oncol\u00f3gica INC, Instituto Nacional de Cancerolog\u00eda, Bogot\u00e1, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4444","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"key":"123464","doi-asserted-by":"crossref","unstructured":"Stempel JM, Hammond SP, Sutton DA, Weiser LM, Marty FM. Invasive fusariosis in the voriconazole era: Single-center 13-year experience. Open forum Infect Dis. 2015;2:1-5. https:\/\/doi.org\/10.1093\/ofid\/ofv099","DOI":"10.1093\/ofid\/ofv099"},{"key":"123465","unstructured":"Bonifaz-Trujillo A. Hialohifomicosis y otras micosis poco frecuentes. En: Serrano H, editor. Micolog\u00eda m\u00e9dica b\u00e1sica. 4\u00aa edici\u00f3n. Ciudad de M\u00e9xico: McGraw-Hill; 2012. p. 440-60."},{"key":"123466","doi-asserted-by":"crossref","unstructured":"Verbeke V, Bourgeois T, Lodewyck T, van Praet J, Lagrou K, Reynders M, et al. Successful outcome of disseminated Fusarium musae fungemia with skin localization treated with liposomal amphotericin B and voriconazole in a patient with acute myeloid leukemia. Mycopathologia. 2020;185:1085-9. https:\/\/doi.org\/10.1007\/s11046-020-00499-w","DOI":"10.1007\/s11046-020-00499-w"},{"key":"123467","doi-asserted-by":"crossref","unstructured":"Campo M, Lewis RE, Kontoyiannis DP. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. J Infect. 2010;60:331-7. https:\/\/doi.org\/10.1016\/j.jinf.2010.01.010","DOI":"10.1016\/j.jinf.2010.01.010"},{"key":"123468","doi-asserted-by":"crossref","unstructured":"Kontoyiannis D, Marr K, Park B, Alexander B, Anaissie E, Walsh T, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: Overview of the TransplantAssociated Infection Surveillance Network (TRANSNET) database. Clin Infect Dis. 2010;50:1091-1100. https:\/\/doi.org\/10.3410\/f.2555970.2208073","DOI":"10.1086\/651263"},{"key":"123469","doi-asserted-by":"crossref","unstructured":"Tortorano AM, Prigitano A, Esposto MC, Arsic Arsenijevic V, Kolarovic J, Ivanovic D, et al. European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe. Eur J Clin Microbiol Infect Dis. 2014;33:1623-30. https:\/\/doi.org\/10.1007\/s10096-014-2111-1","DOI":"10.1007\/s10096-014-2111-1"},{"key":"123470","doi-asserted-by":"crossref","unstructured":"Herkert PF, Al-Hatmi AMS, de-Oliveira GL, Muro MD, Pinheiro RL, Nucci M, et al. Molecular characterization and antifungal susceptibility of clinical Fusarium species from Brazil. Front Microbiol. 2019;10:737. https:\/\/doi.org\/10.3389\/fmicb.2019.00737","DOI":"10.3389\/fmicb.2019.00737"},{"key":"123471","doi-asserted-by":"crossref","unstructured":"V\u00e9lez JD, Fern\u00e1ndez L, Cadavid D, Herrera S, Vallejo S. Fusariosis diseminada con hemoptisis masiva en un paciente con leucemia linfobl\u00e1stica aguda. Infectio. 2012;16:104-7. https:\/\/doi.org\/10.1016\/s0123-9392(12)70034-6","DOI":"10.1016\/S0123-9392(12)70034-6"},{"key":"123472","doi-asserted-by":"crossref","unstructured":"Lobat\u00f3n-Ram\u00edrez J, Coronado-Negrete A, Ram\u00edrez-Barranco R, Rocha-Reyes E, Pinto-Angarita JC, Borr\u00e9-Naranjo D. Fusariosis diseminada por Fusarium verticillioides en un paciente con leucemia mieloide aguda. Rev Cienc Biomed. 2016;7:316-22. https:\/\/doi.org\/10.32997\/rcb-2016-2862","DOI":"10.32997\/rcb-2016-2862"},{"key":"123473","unstructured":"Hern\u00e1ndez-Cruz C, N\u00fa\u00f1ez-Quintana A, Rodr\u00edguez-Fraga Y, Carnot-Uria J, Mu\u00f1\u00edo-Perurena J, P\u00e9rez-Rom\u00e1n G, et al. Sepsis sist\u00e9mica por Fusarium solani en pacientes con leucemias agudas. Reporte de dos casos. Rev Hematol Mex. 2011;12:287-92."},{"key":"123474","doi-asserted-by":"crossref","unstructured":"Garcia RR, Min Z, Narasimhan S, Bhanot N. Fusarium brain abscess: Case report and literature review. Mycoses. 2014;58:22-6. https:\/\/doi.org\/10.1111\/myc.12271","DOI":"10.1111\/myc.12271"},{"key":"123475","doi-asserted-by":"crossref","unstructured":"Delia M, Monno R, Giannelli G, Stabile-Ianora AA, Dalfino L, Pastore D, et al. Fusariosis in a patient with acute myeloid leukemia: A case report and review of the literature. Mycopathologia. 2016;181:457-63. https:\/\/doi.org\/10.1007\/s11046-016-9987-5","DOI":"10.1007\/s11046-016-9987-5"},{"key":"123476","doi-asserted-by":"crossref","unstructured":"Garnica M, Oliveira-da-Cunha M, Portugal R, Maiolino A, Colombo AL, Nucci M. Risk factors for invasive fusariosis in patients with acute myeloid leukemia and in hematopoietic cell transplant recipients. Clin Infect Dis 2015;60:875-80. https:\/\/doi.org\/10.1093\/cid\/ciu947","DOI":"10.1093\/cid\/ciu947"},{"key":"123477","doi-asserted-by":"crossref","unstructured":"Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007;20:695-704. https:\/\/doi.org\/10.1128\/cmr.00014-07","DOI":"10.1128\/CMR.00014-07"},{"key":"123478","unstructured":"Arenas R. Hialohifomicosis y contaminantes de laboratorio. En: de Le\u00f3n J, editor. Micolog\u00eda m\u00e9dica iiustrada. 5\u00aa edici\u00f3n. Ciudad de M\u00e9xico: McGrawHill; 2014. p. 345-64."},{"key":"123479","doi-asserted-by":"crossref","unstructured":"Al-Hatmi AMS, Bonifaz A, Tirado-S\u00e1nchez A, Meis JF, de-Hoog GS, Ahmed SA. Fusarium species causing eumycetoma: Report of two cases and comprehensive review of the literature. Mycoses. 2017;60:204-12. https:\/\/doi.org\/10.1111\/myc.12590","DOI":"10.1111\/myc.12590"},{"key":"123480","doi-asserted-by":"crossref","unstructured":"Nucci F, Nou\u00e9r SA, Capone D, Nucci M. Invasive mould disease in haematologic patients: Comparison between fusariosis and aspergillosis. Clin Microbiol Infect. 2018;24:1105. https:\/\/doi.org\/10.1016\/j.cmi.2018.05.006","DOI":"10.1016\/j.cmi.2018.05.006"},{"key":"123481","doi-asserted-by":"crossref","unstructured":"Olivares R, Alfaro J, D\u00edaz MC, Thompson L. Fusariosis diseminada por Fusarium oxysporum en un paciente adulto con leucemia mieloide aguda y neutropenia severa febril. Rev Chil Infectol. 2005;22:356-60. https:\/\/doi.org\/10.4067\/s0716-10182005000600009","DOI":"10.4067\/S0716-10182005000600009"},{"key":"123482","doi-asserted-by":"crossref","unstructured":"West EK, Mehta M, Patel V, Chamberland R. Skin lesion in a patient after hematopoietic stem cell transplant. Transpl Infect Dis. 2017;19:e12753. https:\/\/doi.org\/10.1111\/tid.12753","DOI":"10.1111\/tid.12753"},{"key":"123483","doi-asserted-by":"crossref","unstructured":"Ersal T, Al-Hatmi ASM, Dalyan-Cilo B, Curfs-Breuker I, Meis JF, \u00d6zkalemka\u015f F, et al. Fatal disseminated infection with Fusarium petroliphilum. Mycopathologia. 2014;179:119-24. https:\/\/doi.org\/10.1007\/s11046-014-9813-x","DOI":"10.1007\/s11046-014-9813-x"},{"key":"123484","doi-asserted-by":"crossref","unstructured":"Avelino-Silva VI, Ramos JF, Leal FE, Testagrossa L, Novis YS. Disseminated Fusarium infection in autologous stem cell transplant recipient. Braz J Infect Dis. 2015;19:90-3. https:\/\/doi.org\/10.1016\/j.bjid.2014.08.009","DOI":"10.1016\/j.bjid.2014.08.009"},{"key":"123485","doi-asserted-by":"crossref","unstructured":"Sganga G, Bianco G, Frongillo F, Lirosi MC, Nure E, Agnes S. Fungal infections after liver transplantation: incidence and outcome. Transplant Proc. 2014;46:2314-8. https:\/\/doi.org\/10.1016\/j.transproceed.2014.07.056","DOI":"10.1016\/j.transproceed.2014.07.056"},{"key":"123486","doi-asserted-by":"crossref","unstructured":"Georgiadou SP, Velegraki A, Arabatzis M, Neonakis I, Chatzipanagiotou S, Dalekos GN, et al. Cluster of Fusarium verticillioides bloodstream infections among immunocompetent patients in an internal medicine department after reconstruction works in Larissa, Central Greece. J Hosp Infect. 2014;86:267-71. https:\/\/doi.org\/10.1016\/j.jhin.2014.01.011","DOI":"10.1016\/j.jhin.2014.01.011"},{"key":"123487","doi-asserted-by":"crossref","unstructured":"Chang DC, Grant GB, O\u2019Donnell K, Wannemuehler KA, Noble-Wang J, Rao CY, et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA. 2006;296:953-63. https:\/\/doi.org\/10.1001\/jama.296.8.953","DOI":"10.1001\/jama.296.8.953"},{"key":"123488","doi-asserted-by":"crossref","unstructured":"Weiel J, Zhang C, Smith J, Wang W, DuPont J, Lian F. Clinicopathologic aspects of ecthyma gangrenosum in pediatric patients a case series and review of the literature. J Clin Anat Pathol. 2013;1:1-5. https:\/\/doi.org\/10.17303\/jcap.2013.101","DOI":"10.17303\/jcap.2013.101"},{"key":"123489","doi-asserted-by":"crossref","unstructured":"Tortorano AM, Richardson M, Roilides E, Van-Diepeningen A, Caira M, Munoz P, et al. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect. 2014;20:27-46. https:\/\/doi.org\/10.1111\/1469-0691.12465","DOI":"10.1111\/1469-0691.12465"},{"key":"123490","doi-asserted-by":"crossref","unstructured":"Marom EM, Holmes AM, Bruzzi JF, Truong MT, O\u2019Sullivan PJ, Kontoyiannis DP. Imaging of pulmonary fusariosis in patients with hematologic malignancies. AJR Am J Roentgenol. 2008;190:1605-9. https:\/\/doi.org\/10.2214\/AJR.07.3278","DOI":"10.2214\/AJR.07.3278"},{"key":"123491","doi-asserted-by":"crossref","unstructured":"Arikan S, Lozano-Chiu M, Paetznick V, Rex JH. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother. 2001;45:327-30. https:\/\/doi.org\/10.1128\/aac.45.1.327-330.2001","DOI":"10.1128\/AAC.45.1.327-330.2001"},{"key":"123492","doi-asserted-by":"crossref","unstructured":"Aperis G, Alivanis P. Posaconazole: a new antifungal weapon. Rev Recent Clin Trials. 2011;6:204-19. https:\/\/doi.org\/10.2174\/157488711796575595","DOI":"10.2174\/157488711796575595"},{"key":"123493","doi-asserted-by":"crossref","unstructured":"Chen SC, Slavin MA, Sorrell TC. Echinocandin antifungal drusi fungal infections: a comparison. Drugs. 2011;71:11-41. https:\/\/doi.org\/10.2165\/11585270-000000000-00000","DOI":"10.2165\/11585270-000000000-00000"},{"key":"123494","doi-asserted-by":"crossref","unstructured":"Martos AI, Romero A, Gonz\u00e1lez MT, Gonz\u00e1les A, Serrano C, Castro C, et al. Evaluation of the E-test method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins. Med Mycol. 2010;48:858-61. https:\/\/doi.org\/10.3109\/13693781003586943","DOI":"10.3109\/13693781003586943"},{"key":"123495","doi-asserted-by":"crossref","unstructured":"Drogari-Apiranthitou M, Mantopoulou FD, Skiada A, Kanioura L, Grammatikou M, Vrioni G, et al. In vitro antifungal susceptibility of filamentous fungi causing rare infections: Synergy testing of amphotericin B, posaconazole and anidulafungin in pairs. J Antimicrob Chemother. 2012;67:1937-40. https:\/\/doi.org\/10.1093\/jac\/dks137","DOI":"10.1093\/jac\/dks137"},{"key":"123496","doi-asserted-by":"crossref","unstructured":"Iqbal NJ, Boey A, Park BJ, Brandt ME. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods. Diagn Microbiol Infect Dis. 2008;62:348-50. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2008.07.003","DOI":"10.1016\/j.diagmicrobio.2008.07.003"},{"key":"123497","doi-asserted-by":"crossref","unstructured":"Stanzani M, Vianelli N, Bandini G, Paolini S, Arpinati M, Bonifazi F, et al. Successful treatment disseminated fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B. J Infect. 2006;53:E243-6. https:\/\/doi.org\/10.1016\/j.jinf.2006.02.011","DOI":"10.1016\/j.jinf.2006.02.011"},{"key":"123498","doi-asserted-by":"crossref","unstructured":"Rojas R, Molina JR, Jarque I, Montes C, Serrano J, Sanz J, et al. Outcome of antifungal combination therapy for invasive mold infections in hematological patients is independent of the chosen combination. Mediterr J Hematol Infect Dis. 2012;4:e2012011. https:\/\/doi.org\/10.4084\/MJHID.2012.011","DOI":"10.4084\/mjhid.2012.011"},{"key":"123499","doi-asserted-by":"crossref","unstructured":"Al-Hatmi AMS, Bonifaz A, Ranque S, Sybren-de-Hoog G, Verweij PE, Meis JF. Current antifungal treatment of fusariosis. Int J Antimicrob Agents. 2018;51:326-32. https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.06.017","DOI":"10.1016\/j.ijantimicag.2017.06.017"},{"key":"123500","doi-asserted-by":"crossref","unstructured":"Lupinetti FM, Giller RH, Trigg MR. Operative treatment of Fusarium fungal infection of the lung. Ann Thorac Surg. 1990;49:991-2. https:\/\/doi.org\/10.1016\/0003-4975(90)90885-a","DOI":"10.1016\/0003-4975(90)90885-A"},{"key":"123501","doi-asserted-by":"crossref","unstructured":"Strom TO, Burmeister RA, Rothenberg GM, Priesand SJ. Treatment of Fusarium osteomyelitis in a diabetic foot ulcer complicated by antineoplastic chemotherapy. Wounds. 2022;34:e37-e41. https:\/\/doi.org\/10.25270\/wnds\/2022.e37e41","DOI":"10.25270\/wnds\/2022.e37e41"},{"key":"123502","doi-asserted-by":"crossref","unstructured":"Vadhan JD, Alyssa JM, Shogan JC, Singh V, Carrillo M. Fast and Fusariosis: A systematic review and case report of a rapidly fatal central nervous system infection. J Emerg Crit Care Med. 2022;6:24. https:\/\/doi.org\/10.21037\/jeccm-21-125","DOI":"10.21037\/jeccm-21-125"},{"key":"123503","doi-asserted-by":"crossref","unstructured":"Guzman-Cottrill JA, Zheng X, Chadwick EG. Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole. Pediatr Infect Dis J. 2004;23:1059-61. https:\/\/doi.org\/10.1097\/01.inf.0000143649.90952.41","DOI":"10.1097\/01.inf.0000143649.90952.41"},{"key":"123504","doi-asserted-by":"crossref","unstructured":"Durand-Joly I, Alfandari S, Benchikh Z, Rodrigue M, Espinel-Ingroff A, Catteau B, et al. Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemia. J Clin Microbiol. 2003;41:4898-900. https:\/\/doi.org\/10.1128\/JCM.41.10.4898-4900.2003","DOI":"10.1128\/JCM.41.10.4898-4900.2003"},{"key":"123505","doi-asserted-by":"crossref","unstructured":"Ho DY, Lee JD, Rosso F, Montoya JG. Treating disseminated fusariosis: amphotericin B, voriconazole or both? Mycoses. 2007;50:227-31. https:\/\/doi.org\/10.1111\/j.1439-0507.2006.01346.xz","DOI":"10.1111\/j.1439-0507.2006.01346.x"},{"key":"123506","doi-asserted-by":"crossref","unstructured":"Nucci M, Anaissie EJ, Queiroz-Telles F, Martins CA, Trabasso P, Solza C, et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer. 2003;98:315-9. https:\/\/doi.org\/10.1002\/cncr.11510","DOI":"10.1002\/cncr.11510"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/6925\/5251","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/6925\/5359","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/6925\/5251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:27:37Z","timestamp":1773840457000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/6925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":43,"journal-issue":{"issue":"Sp. 1","published-online":{"date-parts":[[2023,8,31]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.6925","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"assertion":[{"value":"2023-08-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Presentaci\u00f3n de caso","name":"content_type","label":"Content Type"}]}}